Macimorelin
Also known as: Macrilen, AEZS-130
Key Facts: Macimorelin
- Category
- Hormonal
- FDA Status
- FDA Approved
- Clinical Status
- FDA Approved - Diagnostic for AGHD
- Administration
- Oral solution, fasting
- Typical Dose
- Limited community data available
- Frequency
- See research protocols
- Evidence Level
- FDA Approved
- Duration
- Single diagnostic test
What to Expect
An oral ghrelin mimetic used to diagnose adult growth hormone deficiency. The first FDA-approved oral GH stimulation test.
Mechanism of Action
Macimorelin activates ghrelin receptors (GHSR-1a), stimulating GH release from the pituitary. As an oral agent, it's more convenient than injectable stimulation tests like ITT or glucagon.
Research Summary
Studies showed 92% concordance with insulin tolerance test. Single oral dose followed by blood draws provides reliable AGHD diagnosis. Much safer and simpler than previous gold standard tests.
Dosing Information
Typical Dosingⓘ
Community experience
Limited community data available
See research dosing
See research protocols
Research Dosingⓘ
Scientific studies
FDA-approved diagnostic protocol
Doses from Studies
0.5 mg/kg oral single dose
Duration
Single diagnostic test
Administration
Oral solution, fasting
Timing & Administration
Best Time to Take
Morning or as directed
Follow recommended protocol
Food Recommendation
With or without food
Why This Timing?
Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Taste changes (dysgeusia)
- ●Dizziness
- ●Headache
- ●Nausea
- ●QT prolongation
- ●FDA approved (Macrilen) for diagnostic use
References
Related Peptides
Peptides commonly compared with Macimorelin or used in similar applications.
Gonadorelin
FDAA synthetic version of gonadotropin-releasing hormone. Used diagnostically and therapeutically for various reproductive and hormonal conditions.
HormonalLanreotide
FDAA long-acting somatostatin analog similar to octreotide. FDA approved for acromegaly and gastroenteropancreatic neuroendocrine tumors.
HormonalPegvisomant
FDAA GH receptor antagonist that blocks growth hormone action. Used for acromegaly when surgery and somatostatin analogs fail to normalize IGF-1.
HormonalOxytocin
FDAA naturally occurring peptide hormone crucial for social bonding, childbirth, and lactation. Being studied for autism, anxiety, and social disorders.
HormonalLeuprolide
FDAA GnRH agonist that suppresses testosterone and estrogen production. FDA approved for prostate cancer, endometriosis, uterine fibroids, and precocious puberty.
HormonalDesmopressin
FDAA synthetic analog of vasopressin (ADH) used for diabetes insipidus, bedwetting, and bleeding disorders. Does not cause vasoconstriction like natural vasopressin.
HormonalWant updates on Macimorelin research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.
Educational Information Only
This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.